Agonistic antibody to TLR4/MD-2 protects mice from acute lethal hepatitis induced by TNF-α

被引:28
作者
Akashi-Takamura, Sachiko
Furuta, Takahisa
Takahashi, Koichiro
Tanimura, Natsuko
Kusumoto, Yutaka
Kobayashi, Toshihiko
Saitoh, Shin-ichiroh
Adachi, Yoshiyuki
Doi, Takahiro
Miyake, Kensuke
机构
[1] Univ Tokyo, Inst Med Sci, Div Infect Genet, Minato Ku, Tokyo 1088639, Japan
[2] Japan Sci & Technol, Core Res Engn Sci & Technol, Tokyo, Japan
[3] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Immunopharmacol Microbial Prod, Tokyo, Japan
[4] RIKEN, Tsukuba Inst, Bioresource Ctr, Subteam BioSignal Integrat,Technol & dev Team Bio, Ibaraki, Japan
关键词
D O I
10.4049/jimmunol.176.7.4244
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
LPS is recognized by a heterodimer consisting of TLR4 and its coreceptor MD-2. LPS signal causes excessive inflammation and tissue damage. In this study, we show that a mAb to TLR4/MD-2 protected mice from acute lethal hepatitis caused by LPS/D-galactosamine. The protective effect of the mAb was not due to inhibition of LPS response, because serum TNF-alpha, which was induced by LPS and caused lethal hepatitis, was 10 times up-regulated by the mAb pretreatment. Moreover, this mAb induced antiapoptotic genes in liver in a TLR4/MD-2-dependent manner. These results demonstrated that an agonistic mAb to TLR4/ MD-2 protected mice from LPS/D-galactosamine-induced acute lethal hepatitis by delivering a protective signal activating NF-kappa B through TLR4/MD-2.
引用
收藏
页码:4244 / 4251
页数:8
相关论文
共 34 条
[1]   Lipopolysaccharide interaction with cell surface toll-like receptor 4-MD-2: Higher affinity than that with MD-2 or CD14 [J].
Akashi, S ;
Saitoh, S ;
Wakabayashi, Y ;
Kikuchi, T ;
Takamura, N ;
Nagai, Y ;
Kusumoto, Y ;
Fukase, K ;
Kusumoto, S ;
Adachi, Y ;
Kosugi, A ;
Miyake, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (07) :1035-1042
[2]   A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis [J].
Arvelo, MB ;
Cooper, JT ;
Longo, C ;
Daniel, S ;
Grey, ST ;
Mahiou, J ;
Czismadia, E ;
Abu-Jawdeh, G ;
Ferran, C .
HEPATOLOGY, 2002, 35 (03) :535-543
[3]   The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses [J].
Boone, DL ;
Turer, EE ;
Lee, EG ;
Ahmad, RC ;
Wheeler, MT ;
Tsui, C ;
Hurley, P ;
Chien, M ;
Chai, S ;
Hitotsumatsu, O ;
McNally, E ;
Pickart, C ;
Ma, A .
NATURE IMMUNOLOGY, 2004, 5 (10) :1052-1060
[4]   Endotoxin tolerance - current concepts in historical perspective [J].
Cross, AS .
JOURNAL OF ENDOTOXIN RESEARCH, 2002, 8 (02) :83-98
[5]   Overexpressin of A20 in endothelial cells of vascularized grafts creates a protective barrier against TNF- and FAS-mediated apoptosis [J].
Daniel, S ;
Arvelo, M ;
Ferran, C .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) :225-225
[6]   Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling [J].
De Smaele, E ;
Zazzeroni, F ;
Papa, S ;
Nguyen, DU ;
Jin, RG ;
Jones, J ;
Cong, R ;
Franzoso, G .
NATURE, 2001, 414 (6861) :308-313
[7]   Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality [J].
Doi, TS ;
Marino, MW ;
Takahashi, T ;
Yoshida, T ;
Sakakura, T ;
Old, LJ ;
Obata, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :2994-2999
[8]   Human Toll-like receptor 4 recognizes host-specific LPS modifications [J].
Hajjar, AM ;
Ernst, RK ;
Tsai, JH ;
Wilson, CB ;
Miller, SI .
NATURE IMMUNOLOGY, 2002, 3 (04) :354-359
[9]  
Hoshino K, 1999, J IMMUNOL, V162, P3749
[10]   Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells [J].
Hu, XL ;
Yee, E ;
Harlan, JM ;
Wong, F ;
Karsan, A .
BLOOD, 1998, 92 (08) :2759-2765